Skip to main content

Credit Suisse, SEC letters show months-long reporting errors debate

Credit Suisse, SEC letters show months-long reporting errors debate: The last-minute delay concerned analysts and sent Credit Suisse shares to near an all-time low. The back-and-forth between the bank and the U.S. regulator extended into another week as turmoil gripped the banking sector. As recently as March 10, the SEC asked the bank to explain how it decided that an "entity-level material weakness did not exist" for its 2021 and 2022 financial years. Material weaknesses are considered the most serious of such control failures. In previous letters to the SEC in August and November, Credit Suisse's former chief financial officer David Mathers and his successor Dixit Joshi described the failings as "deficiencies", which are considered to be less serious. In the March 10 letter to Joshi, SEC staff acknowledged discussions with the bank on March 8-10. Joshi responded on March 12, saying in a letter that the firm noted the concerns and had reassessed its position. "We will report that we have, and have had, a material weakness in internal control over financial reporting..." he said in the letter posted on the SEC online database. Credit Suisse notified shareholders of the weaknesses in its annual report on March 14, the day before it was granted a liquidity lifeline by the Swiss National Bank. This proved insufficient and on March 19, the bank's takeover by Swiss rival UBS was announced. The SEC's chief accountant in March 2022 warned public companies away from a bias toward deeming accounting errors immaterial for investors. Material weaknesses are unusual among large, sophisticated companies, said Miguel Angel Minutti-Meza, accounting department chair at the University of Miami. "Once you get to the top bracket, it is very rare to see these issues," he said. "Investors will wonder: how could you not fix these?"

Popular posts from this blog

Elizabeth Holmes Discusses Theranos at WSJDLive 2015

Elizabeth Holmes Discusses Theranos at WSJDLive 2015 Elizabeth Holmes Discusses Theranos at WSJDLive 2015 At the WSJDLive 2015 conference, Theranos founder and CEO Elizabeth Holmes discusses her company's proprietary technologies, the FDA's inspection of its facilities, and the assertion that her company was too quick to market its products.